Skip to main content
News BMZ II

News categories: Honors & Funding

ImmunoSensation members among "highly cited researchers"

Five scientists from ImmunoSensation2 are among the world's most cited researchers, annualy published by the information service provider Clarivate Analytics. Once more, Prof. Joachim Schultze (DZNE), Prof. Andreas Schlitzer (LIMES) and Prof. Eicke Latz (DRFZ), Prof. Jonathan Schmid-Burgk (UKB) and Thomas Bieber (UKB) are part of the impressive list.

According to the compilers of the ranking, the people on this list of ‘Highly Cited Researchers’ are among the world's most influential one per cent in their field. The list contains around 6,600 researchers from 59 countries. From Germany, 332 researchers have made it onto the list - including ten from the University of Bonn


The benchmark is the frequency with which scientific publications have been cited by other researchers in the last ten years (period from 2013 to 2023). For the analysis, the creators of the list divided the publications into 20 subject areas and introduced the ‘Cross-Field’ section, which lists researchers who have published in several subject areas.

The ranking is published annually by the ‘Web of Science Group’ and can be found here.

 

Related news

Niklas Klümper

News categories: Honors & Funding

Niklas Klümper Receives Johann-Georg-Zimmermann Prize

PD Dr. Niklas Klümper was honored with the prestigious Johann-Georg-Zimmermann Research Prize. The €10,000 award is presented annually to young cancer researchers for their current scientific contributions.
View entry
Speakers of ImmunoSensation

News categories: Honors & Funding

ImmunoSensation goes into the next round

The Bonn Cluster of Excellence ImmunoSensation will be funded for further seven years as part of the Excellence Strategy of the German federal and state governments. The aim of the new funding period, which begins on January 1, 2026, is to research immune diversity: the structural, functional and dynamic diversity of the immune system. Involved are the University of Bonn, the University Hospital Bonn (UKB) and the German Center for Neurodegenerative Diseases (DZNE). The funding amounts to around 50 million euros.
View entry
Kerstin Ludwig

News categories: Honors & Funding

Genome data to improve diagnosis and treatment of long Covid

Despite the many advances, there are still major gaps in the care of patients with long-term and post-COVID. The Institute of Human Genetics at the UKB in Bonn now begins a genomLC study as part of a BMG funding priority. The researchers want to help speed up the diagnosis of long- and post-COVID and identify possible biomarkers that could possibly also differentiate between subgroups of the diseases. To this end, the genomic data of those affected is being analyzed as part of a study using blood samples. The project is funded by the Federal Ministry of Health (BMG) with 1.34 million euros.
View entry

Back to the news overview